A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice
© 2022. The Author(s)..
Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, the innate mechanisms of 3M-052 have not been fully characterized. Here, we perform flow cytometry, single cell RNA-seq and ATAC-seq to profile the kinetics, transcriptomics and epigenomics of innate immune cells in murine draining lymph nodes following 3M-052-Alum/Ovalbumin immunization. We find that 3M-052-Alum/OVA induces a robust antiviral and interferon gene program, similar to the yellow fever vaccine, which is known to confer long-lasting protection. Activation of myeloid cells in dLNs persists through day 28 and single cell analysis reveals putative TF-gene regulatory programs in distinct myeloid cells and heterogeneity of monocytes. This study provides a comprehensive characterization of the transcriptomics and epigenomics of innate populations in the dLNs after vaccination.
Medienart: |
E-Artikel |
---|
Erscheinungsjahr: |
2022 |
---|---|
Erschienen: |
2022 |
Enthalten in: |
Zur Gesamtaufnahme - volume:13 |
---|---|
Enthalten in: |
Nature communications - 13(2022), 1 vom: 27. Jan., Seite 549 |
Sprache: |
Englisch |
---|
Beteiligte Personen: |
Lee, Audrey [VerfasserIn] |
---|
Links: |
---|
Anmerkungen: |
Date Completed 17.02.2022 Date Revised 16.12.2022 published: Electronic Citation Status MEDLINE |
---|
doi: |
10.1038/s41467-022-28197-9 |
---|
funding: |
|
---|---|
Förderinstitution / Projekttitel: |
|
PPN (Katalog-ID): |
NLM336214448 |
---|
LEADER | 01000naa a22002652 4500 | ||
---|---|---|---|
001 | NLM336214448 | ||
003 | DE-627 | ||
005 | 20231225231630.0 | ||
007 | cr uuu---uuuuu | ||
008 | 231225s2022 xx |||||o 00| ||eng c | ||
024 | 7 | |a 10.1038/s41467-022-28197-9 |2 doi | |
028 | 5 | 2 | |a pubmed24n1120.xml |
035 | |a (DE-627)NLM336214448 | ||
035 | |a (NLM)35087093 | ||
040 | |a DE-627 |b ger |c DE-627 |e rakwb | ||
041 | |a eng | ||
100 | 1 | |a Lee, Audrey |e verfasserin |4 aut | |
245 | 1 | 2 | |a A molecular atlas of innate immunity to adjuvanted and live attenuated vaccines, in mice |
264 | 1 | |c 2022 | |
336 | |a Text |b txt |2 rdacontent | ||
337 | |a ƒaComputermedien |b c |2 rdamedia | ||
338 | |a ƒa Online-Ressource |b cr |2 rdacarrier | ||
500 | |a Date Completed 17.02.2022 | ||
500 | |a Date Revised 16.12.2022 | ||
500 | |a published: Electronic | ||
500 | |a Citation Status MEDLINE | ||
520 | |a © 2022. The Author(s). | ||
520 | |a Adjuvants hold great potential in enhancing vaccine efficacy, making the understanding and improving of adjuvants critical goals in vaccinology. The TLR7/8 agonist, 3M-052, induces long-lived humoral immunity in non-human primates and is currently being evaluated in human clinical trials. However, the innate mechanisms of 3M-052 have not been fully characterized. Here, we perform flow cytometry, single cell RNA-seq and ATAC-seq to profile the kinetics, transcriptomics and epigenomics of innate immune cells in murine draining lymph nodes following 3M-052-Alum/Ovalbumin immunization. We find that 3M-052-Alum/OVA induces a robust antiviral and interferon gene program, similar to the yellow fever vaccine, which is known to confer long-lasting protection. Activation of myeloid cells in dLNs persists through day 28 and single cell analysis reveals putative TF-gene regulatory programs in distinct myeloid cells and heterogeneity of monocytes. This study provides a comprehensive characterization of the transcriptomics and epigenomics of innate populations in the dLNs after vaccination | ||
650 | 4 | |a Journal Article | |
650 | 4 | |a Research Support, N.I.H., Extramural | |
650 | 4 | |a Research Support, Non-U.S. Gov't | |
650 | 7 | |a Adjuvants, Immunologic |2 NLM | |
650 | 7 | |a Alum Compounds |2 NLM | |
650 | 7 | |a Antibodies, Viral |2 NLM | |
650 | 7 | |a Membrane Glycoproteins |2 NLM | |
650 | 7 | |a TLR7 protein, human |2 NLM | |
650 | 7 | |a TLR8 protein, human |2 NLM | |
650 | 7 | |a TLR8 protein, mouse |2 NLM | |
650 | 7 | |a Tlr7 protein, mouse |2 NLM | |
650 | 7 | |a Toll-Like Receptor 7 |2 NLM | |
650 | 7 | |a Toll-Like Receptor 8 |2 NLM | |
650 | 7 | |a Vaccines, Attenuated |2 NLM | |
650 | 7 | |a ovalbumin-alum |2 NLM | |
650 | 7 | |a Ovalbumin |2 NLM | |
650 | 7 | |a 9006-59-1 |2 NLM | |
700 | 1 | |a Scott, Madeleine K D |e verfasserin |4 aut | |
700 | 1 | |a Wimmers, Florian |e verfasserin |4 aut | |
700 | 1 | |a Arunachalam, Prabhu S |e verfasserin |4 aut | |
700 | 1 | |a Luo, Wei |e verfasserin |4 aut | |
700 | 1 | |a Fox, Christopher B |e verfasserin |4 aut | |
700 | 1 | |a Tomai, Mark |e verfasserin |4 aut | |
700 | 1 | |a Khatri, Purvesh |e verfasserin |4 aut | |
700 | 1 | |a Pulendran, Bali |e verfasserin |4 aut | |
773 | 0 | 8 | |i Enthalten in |t Nature communications |d 2010 |g 13(2022), 1 vom: 27. Jan., Seite 549 |w (DE-627)NLM199274525 |x 2041-1723 |7 nnns |
773 | 1 | 8 | |g volume:13 |g year:2022 |g number:1 |g day:27 |g month:01 |g pages:549 |
856 | 4 | 0 | |u http://dx.doi.org/10.1038/s41467-022-28197-9 |3 Volltext |
912 | |a GBV_USEFLAG_A | ||
912 | |a GBV_NLM | ||
951 | |a AR | ||
952 | |d 13 |j 2022 |e 1 |b 27 |c 01 |h 549 |